Jim Simons’s Aegerion Pharmaceuticals AEGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-1,716,200
| Closed | -$5.1M | – | 3645 |
|
|
2016
Q3 | $5.1M | Buy |
1,716,200
+346,700
| +25% | +$601K | 0.01% | 1589 |
|
|
2016
Q2 | $2.04M | Buy |
1,369,500
+593,071
| +76% | +$1.36M | ﹤0.01% | 2183 |
|
|
2016
Q1 | $2.87M | Buy |
776,429
+650,529
| +517% | +$4.03M | 0.01% | 2001 |
|
|
2015
Q4 | $1.27M | Sell |
125,900
-106,900
| -46% | -$1.29M | ﹤0.01% | 2348 |
|
|
2015
Q3 | $3.17M | Buy |
232,800
+73,225
| +46% | +$1.3M | 0.01% | 1692 |
|
|
2015
Q2 | $3.03M | Buy |
+159,575
| New | +$3.45M | 0.01% | 1781 |
|
|
2014
Q4 | – | Sell |
-89,000
| Closed | -$2.97M | – | 3249 |
|
|
2014
Q3 | $2.97M | Buy |
89,000
+12,500
| +16% | +$388K | 0.01% | 1454 |
|
|
2014
Q2 | $2.46M | Buy |
+76,500
| New | +$2.85M | 0.01% | 1620 |
|
|
2013
Q4 | – | Sell |
-52,800
| Closed | -$4.53M | – | 3142 |
|
|
2013
Q3 | $4.53M | Buy |
+52,800
| New | +$4.48M | 0.01% | 1211 |
|
Jim Simons's AEGR Position: Q4 2016 in Review
Jim Simons sold out of Aegerion Pharmaceuticals (AEGR) in Q4 2016, closing a stake of 1,716,200 shares — an estimated $5.1M sold.
Jim Simons first reported a position in AEGR in Q3 2013 and held it in 9 quarters. The position peaked at $5.1M in Q3 2016. 0 funds tracked by Wall St. Rank hold AEGR as of Q4 2016.
- Jim Simons reported no remaining Aegerion Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
- Jim Simons sold 1,716,200 Aegerion Pharmaceuticals shares in Q4 2016, an estimated $5.1M.
- Jim Simons first reported a position in Aegerion Pharmaceuticals in Q3 2013 and held it in 9 quarters.
- Jim Simons's Aegerion Pharmaceuticals position peaked at $5.1M in Q3 2016.
- 0 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q4 2016.
Based on Renaissance Technologies's 13F filing for Q4 2016, filed 13 Feb 2017.